Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial
Authors:
- Stacey B. ArmstrongSAStacey B. Armstrong
- Adam W. LevinALAdam W. Levin
- Nathan D. SepedaNSNathan D. Sepeda
- Hillary ShaubHSHillary Shaub
- Taweh HunterTHTaweh Hunter
- Angela DouglasADAngela Douglas
- Rafaelle LancelottaRLRafaelle Lancelotta
- Alan K. DavisADAlan K. Davis
Open Access
- 30 July 2026
- journal article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Suicide Risk Evaluations and Suicide in the Veterans Health AdministrationJAMA Network Open, 2025
- Adverse Events in Studies of Classic PsychedelicsJAMA Psychiatry, 2024
- Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological InterventionsJAMA Network Open, 2024
- Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry, 2021
- The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-IIISocial Psychiatry and Psychiatric Epidemiology, 2016
- The Posttraumatic Stress Disorder Checklist for DSM‐5 (PCL‐5): Development and Initial Psychometric EvaluationJournal of Traumatic Stress, 2015
- A Systematic Review of Dropout From Psychotherapy for Posttraumatic Stress Disorder Among Iraq and Afghanistan Combat VeteransJournal of Traumatic Stress, 2015
- Psychotherapy for Military-Related PTSDJAMA, 2015
- Personality Assessment Inventory ( PAI )2015
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005